ICTI to Speak on Adaptive Trial Design at Brussels Conference

April 25, 2006

Interactive Clinical Technologies Inc.(ICTI) will be speaking at the Institute for International Research’s “Adaptive Designs for Clinical Development” Conference. This year’s conference, being held on 25-26 April, 2006 in Brussels, will include sessions from ICTI’s Vice President of Clinical Services, Valarie Higgins and Associate Director of Biostatistics, Eva Miller, Ph.D.. Ms. Higgins will present “The Use of IVRS & EDC to aid in the Implementation of Adaptive Trial Designs”, and Mrs. Miller will be presenting “Adaptive Randomization: Subject Allocation to Treatment Rules”.

Richard McCann, ICTI’s President, noted, “These two topics are at the epicenter of the process and technology trends that we are seeing throughout the industry. We are enthused by this opportunity to share our expertise on the subject of Adaptive Trial Design at this prestigious conference.”

About ICTI and Almac Sciences

ICTI has been implementing adaptive randomization designs since 1999, and its technologies and services have been used in over 60 adaptive randomization studies. ICTI is a division of Almac Sciences that specializes in interactive solutions to accelerate the clinical trials process and reduce the costs of clinical trials. Our solutions include Interactive Voice and Web Response Systems (iXRS) for patient randomization, dosing and clinical supply inventory management; iDiary phone-based patient diary data collection; iTrial EDC for electronic case report form (eCRF) data collection; and forecasting for clinical trials supplies planning.

Almac Sciences and its affiliated companies (CSS (Chemical Synthesis Services), CTS (Clinical Trial Services), ICTI (Interactive Clinical Technologies Incorporated), PDMS (Pharmaceutical Development and Manufacturing Services) and Almac Diagnostic Services) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.

Contact Jim Murphy or Meghan Adams US: 267-685-4284

clinicaltechnologies@almacgroup.com

Share

Back to news